Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
100%(3 trials)

Phase Distribution

Ph phase_1
1
33%
Ph phase_3
1
33%
Ph phase_4
1
33%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_1

Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.

NCT06729073
completedphase_3

Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study

NCT04052620
completedphase_4

Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain

NCT01335724

Clinical Trials (3)

Showing 3 of 3 trials
NCT06729073Phase 1

Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.

Completed
NCT04052620Phase 3

Voltaren Emulgel 2% Acute Ankle Sprain Non Inferiority Study

Completed
NCT01335724Phase 4

Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3